2020-2027 Analysis and Review Endocrinology Hormone Reagents Market

Endocrinology Hormone Reagents Market

Endocrinology Hormone Reagents Market By Test Type (Thyroid Stimulating Hormone (TSH) Test, Insulin Test, Human Chorionic Gonadotropin (hCG) Test and Others), By End User (Diagnostic Centers, Academic Research Institutes and Others - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

09-07-2020 REP-HC-5129 40 Tables 120 pages Format

The endocrinology hormone reagents market was valued at USD 4,174.3 Mn by 2019. Rising prevalence of endocrine diseases causing hormonal imbalance in the human body across the globe primarily drives the endocrinology hormone reagents market. Furthermore increasing public health awareness resulting in early diagnosis and screening further accentuates the market growth.

Endocrinology Hormone Reagents Market

Endocrinology is a branch of medical science which studies the disorders and medicines pertaining to the hormonal secretions associated with the human endocrine system. Proactive role adopted by government healthcare agencies in establishing a point of care and diagnostic centers to perform early screening of hormonal imbalance associated with lifestyle disorders has increased the traction for endocrinology hormone reagents.

The major segments related to the endocrinology hormone reagents market are: 

By Test Type (2017–2027; US$ Mn)

Thyroid Stimulating Hormone (TSH) Test

Insulin Test

Human Chorionic Gonadotropin (hCG) Test

Others

By End User (2017–2027; US$ Mn)

Diagnostic Centers

Academic Research Institutes

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global endocrinology hormone reagents market
  • The overall segmentation of the endocrinology hormone reagents market, by test type, end-user, and geography is minutely studied. TSH Test and diagnostic centers are dominating the test type and end-user segments respectively
  • Rising prevalence of endocrine diseases worldwide resulting in the fluctuation of endocrine hormone levels thereby causing chronic diseases
  • Increasing public health awareness pertaining to hormonal imbalance thereby resulting in early diagnosis and screening

Report gist?

  • The study of the global endocrinology hormone reagents market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers the qualitative and quantitative analysis of the overall market segmented on the basis of test type and end-user and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the immunoassay reagent manufacturers actively engaged in the production and marketing of endocrinology hormone reagents due to the  rising prevalence of the endocrine disease worldwide
  • The report will benefit healthcare professionals engaged in the screening and diagnosis of hormonal imbalance associated with chronic lifestyle disorders across the globe
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to endocrinology hormone reagents market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

The thyroid-stimulating hormone (TSH) test is representing the largest market share in the endocrinology hormone reagents market. The rising prevalence of thyroid disorder worldwide determines its market growth. As per the latest research citings provided by the American Thyroid Association (ATA), it is estimated that approximately 60% of the individuals suffering from thyroid disease are unaware of their condition and further clinical studies have elucidated that women are 8 times more susceptible to develop early thyroid disease as compared to men population across the globe. The insulin test will be recording exemplary market performance during the forecast period primarily due to the rising prevalence of type 2 diabetes worldwide. According to the recent statistics provided by the International Diabetes Federation (IDF) in 2019, it is estimated that 463 million people worldwide were reported to be suffering from diabetes.

Diagnostic centers are presently dominating the end-user segment for the endocrinology hormone reagents market. Rising prevalence of chronic lifestyle disorders associated with endocrine hormonal imbalance and increasing public health awareness resulting in early diagnosis together drive the market growth. Academic research institutes are expected to register excellent market growth owing to the increasing demand for biomolecules for the treatment of cancer and other chronic lifestyle disorders, thereby increasing the demand for endocrinology hormone reagents market.

North America is currently leading the geography segment for the endocrinology hormone reagents market. Existence of well-developed diagnostic centers and point of care medical institutes primarily drives the endocrinology hormone reagents market in the region. Additionally, the domicile of major players such as Abbott Laboratories, Inc., Agilent Technologies, Inc., Quest Diagnostics, Thermo Fisher Scientific, etc further consolidates the market growth in the region. Europe is the second-largest regional segment owing to the increasing public health awareness resulting in early diagnosis and screening and nurturing regulatory environment provided by the European Medical Agency (EMA) for the sale and distribution of endocrine hormone reagents in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the endocrinology hormone reagents market. Developing healthcare infrastructure and a significant increase in the number of government-funded diagnostic centers will determine the market growth in the region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.